Form Type: 4

SEC EDGAR Link
Accession Number:0001213900-22-034071
Date:2022-06-16
Issuer: AUGMEDIX, INC. (AUGX)
Original Submission Date:

Reporting Person:

TRAYLOR MARGIE L.
C/O AUGMEDIX, INC.
111 SUTTER STREET, SUITE 1300 SAN FRANCISCO, CA 94104

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 1.9 2022-06-16 deemed execution date A 52,632 (a) common stock 52,632 $1.90 52,632 direct
Footnotes
IDfootnote
f1 the restricted stock unit ("rsu") is granted under the augmedix, inc. (the "issuer") 2020 equity incentive plan. each rsu represents a contingent right to receive one share of issuer's common stock.
f2 the rsu will vest in full on the one-year anniversary of june 16, 2022, so long as the reporting person remains a director on such date.
WhaleWisdom Logo

Elevate your investments